Subscribe to Search results

It was acknowledged that recent research had shown that viruses other than Hepatitis A and B may have caused significant amount of post-transfusion hepatitis.

Published on:

Hemofil was given to one child as part of the study; he did not bleed frequently and so needed only limited treatment, but went on to develop acute hepatitis.

Published on:

Dr Kirk wrote to parents of a student at Treloar's to inform them their son had been "selected to receive only Kryobulin when he requires transfusing. By limiting him to this type of factor VIII containing material it will be easier to trace the source should he contract hepatitis."

Published on:

A letter about a Treloar's pupil written to his home clinician showed that there had been no advance discussion about the research on him.

Published on:

Dr Kirk proposed to restrict patients to either commercial concentrates as a group or cryoprecipitate or Lister Concentrate as part of the next stage of a hepatitis study.

Published on:

Dr Craske from the Public Health Laboratory Service encouraged further study of hepatitis associated with the use of commercial Factor 8.

Published on:

Dr Craske encouraged further research and applied for a research grant on hepatitis associated with the use of commercial Factor 8.

Published on:

There was a trial to see which of three dosage regimes addressed bleeds into knee, elbow and ankle joints most effectively. This involved pupils being given doses of 7, 14, or 28 units (per kilogram of their bodyweight), and was written up in The Lancet.

Published on:

A report of a trial stated that there was "growing evidence that chronic hepatitis was a not-uncommon consequence of transfusion", related to the total number of donors to whose blood a patient had been exposed.

Published on:

Gary Bennett, a student at Treloar's, was put on "long term prophylaxis" for which three different types of concentrate were used.

Published on:

Gary Bennett, a student at Treloar's, was one of seven pupils put on a trial of DDAVP.

Published on:

Dr Rizza wrote to Dr Aronstam to ask that Leigh Peach, a student at Treloar's, could be supplied with NHS Factor concentrate when trained to treat himself.

Published on:

Leigh Peach, a student at Treloar's, was treated with NHS Factor Concentrate ("Lister") but mainly Koate, Hemofil, and Factorate.

Published on:

Leigh Peach's mother was asked for her consent for him to take part in an unspecified trial.

Published on:

Dr Kirk wrote to Dr Raper speaking of his co-operation in "the Hepatitis Study" by making available Kryobulin for routine treatment.

Published on:

The father of Lee Stay, a Treloar's student, gave his consent for a trial as explained by Dr Aronstam.

Published on:

Dr Painter asserted that there was no risk of contracting hepatitis from the proposed treatment.

Published on:

The Treloar's headmaster told parents that during his work Dr Rainsford would "collect information regarding the incidence of joint and muscle haemorrhage" and implied that this was a "study", and also stated that he was "sure that the new medical arrangements are very much in your son's interest".

Published on:

Dr Arblaster asked a student's father's "co-operation" in the improvement of haemophilia treatment when he agreed to give the patient regular weekly injections of concentrated material.

Published on:

Doctors Arblaster, Rainsford and Aronstama informed parents of a student at the Lord Mayor Treloar College that a new form of treatment would be used and offered a meeting to discuss the details.

Published on: